The GLP-1 Loss That Isn't a Win (and How You Can Stop It)
I watch the same narrative unfold in my clinic: a woman started microdosing a GLP-1, the scale was too fast, and before she could even blink everyone was congratulating her before she even realized what else was happening. Weeks, months later, she’ll tell me that she doesn’t feel as strong as she used to, she still feels bloated, her back hurts more than it ever has, and she’s more exhausted by midafternoon than her schedule would suggest she should be.
What she didn’t realize going in is what actually happens to the rest of the body during rapid weight loss.
What The Scale Doesn’t Tell Her
Rapid weight loss isn’t as selective as we’d like to think: the body doesn’t just burn fat, it burns muscle in a way most people don’t account for in their calculations. In the STEP 1 trial, about 45% of the total weight lost was lean mass, rather than fat. With weight loss from calorie restriction, about 10–30% of the weight lost can come from fat-free mass, which includes muscle, water, and other non-fat tissue. About half of that loss may come from skeletal muscle. Men also tend to lose more lean mass than women. Data suggests that, in women who lose weight without strength training, about 10–15% of total weight loss may come from muscle. This is important because weight loss from GLP-1 and other incretin-based medications, as well as weight-loss surgery, may result in about one-third of total weight loss coming from fat-free mass. This can be higher than what is seen with weight-loss programs that include exercise and strength training.
This isn’t a rounding error. This is a notable chunk of the tissue responsible for your metabolism, your blood sugar regulation, your posture, and your ability to still get up off the floor without thinking about it when you’re 75.
Let me explain the physiology because I think context changes how women respond to this. Estrogen plays a role in muscle protein synthesis, and testosterone (that women also have) influences strength and lean mass retention. When you pair a GLP-1 with an inadequate plan for protein and resistance training, those systems can’t accomplish what they’re designed to accomplish and muscle loss compounds silently, particularly for women 35 and older who are already experiencing lean mass loss more quickly than they were 10 years ago, and who see that even further accelerate during perimenopause and menopause.
Why This Is Being Missed
I’m not here to scare people about a drug that has truly changed the lives of so many of my patients. This isn’t about the drug failing anybody. This is about how we missed a step in the conversation.
Somewhere in time, the scale became the narrative, and a lower number, even when a notable portion of that number was muscle, became an unqualified win for which nobody looked up and asked how she felt strong, the number that actually predicts how she’ll move and function a decade from now quietly dropping out of the conversation altogether.
Women who reload weight after stopping a GLP-1 tend to gain fat back rather than muscle, which compounds the problem over time, and that single fact should change how urgent this becomes. This isn’t about how she feels during the protocol. This is about what her body looks like afterward.
What Actually Protects Her
This isn’t complicated. Just strength train 2 to 3 days a week for about 60 to 90 total minutes, and macronutrient appropriately for protein at every meal (about 20g to 30g per meal) rather than letting a repressed appetite quietly take it out. Target the things that are most important for long-term function: the glutes and legs for metabolism and joints, the back muscles for posture, the deep core for stability, and the upper body for bone density. Resistance training during caloric restriction can reduce lean-mass loss by 50–95%.
None of this takes more than a few hours a week. It just requires us to treat strength training as nonnegotiable the same way we treat the medication itself as nonnegotiable once the doctor writes the prescription. The women in my practice who incorporate this always tell me the same thing after a few weeks. They do feel smaller, but they also feel strong again, which is the part that actually matters.
The Fundamentals Everyone Skips
I keep a mental list of the questions I wish every woman asked before her first dose of a microdosed GLP-1, and almost none of them are actually about the medication itself.
The pattern I see in my practice is fairly consistent. A woman starts microdosing, her appetite quiets down in a way that feels like relief at first, meals shrink, snacks disappear, and food starts to feel like an afterthought rather than something to plan around. Somewhere inside that quiet, protein is usually the first thing to disappear, often without anyone noticing until months later when fatigue sets in and nobody can quite explain why.
Protein: The Piece That Quietly Gets Missed
For most women on a microdosed GLP-1, I want to see somewhere around 80 to 100 or more grams of protein a day, spread across meals at roughly 20 to 30 grams each, which isn’t about eating more so much as eating with intention when there’s far less room on the plate than there used to be.
The starting point I give patients is straightforward, 0.6 to 0.8 grams of protein per pound of goal body weight, which for a woman with a goal weight of 150 pounds lands somewhere between 90 and 120 grams daily. Chicken, fish, Greek yogurt, cottage cheese, tofu, or a scoop of protein powder in a smoothie can all get her there without any of it needing to be complicated, since consistency matters far more than precision.
Fiber And Electrolytes Follow The Same Pattern
As intake drops, so does the incidental sodium, potassium, and magnesium that used to come along with bigger meals, and women often end up dealing with constipation, headaches, or dizziness that gets blamed on the medication itself rather than on what quietly disappeared from the plate. The target here doesn’t need to be exact, since 20 to 30 grams of fiber a day paired with hydration supported by a lightly salted meal or an electrolyte drink is usually enough to remove a whole category of symptoms that get wrongly chalked up to just how the medication feels.
Blood Sugar: The Piece Nobody Talks About
This is, in my opinion, the most under-discussed part of the entire conversation. These medications blunt hunger cues, which makes it remarkably easy to go long stretches without eating, especially for active women who have spent years treating pushing through discomfort as a badge of honor.
Low blood sugar without diabetes is more common on these medications than most people expect, and it tends to show up as shakiness, lightheadedness, irritability, or a wave of fatigue that seems to come out of nowhere. The fix isn’t more discipline, but more consistent fueling, which means something with protein every three to five hours while awake, carbohydrates paired with protein rather than eaten alone, and a small snack before any long or intense activity.
Movement: Where I See The Most Confusion
Cardio deserves its own mention here, because I watch women get this backwards constantly. More cardio is not the answer while eating less, since steady-state movement, daily steps, and a strength training foundation do more for metabolic health long term than an exhausting session that eats into recovery and competes with the training that actually protects results. I generally point patients toward strength as the non-negotiable and cardio as the layer built around it, not the other way around.
None of this is complicated once it’s laid out clearly, which is precisely the problem, since almost no one is laying it out clearly. What it requires is shifting the question from how much weight am I losing this week, to whether this body is actually being given what it needs to do the work being asked of it, and that shift is the entire difference between a GLP-1 used well and a GLP-1 used at the expense of the very health it was meant to protect.